MORE►
Soleo Health
Soleo Health CIO Jason Weems [Photo: Business Wire]
North Texas’ Soleo Health Taps Tech Leader as Its First Chief Information Officer
by Lance Murray | Sep 27, 2024
Jason Weems, who has led tech innovation efforts at Cigna and Evernorth, joins Frisco-based Soleo Health as its first Chief Information Officer. Weems brings a personal drive to his new role, drawing on his own experiences navigating the healthcare system for his daughter’s care.
by Lance Murray |
Mar 22, 2023
Through his board position, Drew Walk hopes to advance key issues in healthcare industry such as adapting to regulatory changes, improving reimbursement practices, and promoting the use of technology in patient-provider and patient-pharmacy communication, especially with the rise of telehealth initiatives.
MORE►
by Lance Murray |
Feb 10, 2023
Susan Faust has been appointed to the newly created role of chief strategy officer by Frisco-based Soleo Health, a national provider of complex specialty pharmacy services.
In her new role, Faust will guide Soleo Health’s strategic initiatives, expanding its position with pharmaceutical manufacturers, payors, health systems, and providers, Soleo said.
“We created the chief strategy officer position because we believe our recent growth warranted the development and implementation of cohesive, dedicated strategic initiatives to take our company to the next level,” Drew Walk, Soleo Health chief executive officer, said in a statement....
MORE►
by David Seeley |
Jan 18, 2023
Frisco-based pharmacy services provider Soleo Health has been selected by Eisai Inc. as the sole specialty pharmacy distribution partner for Leqembi (lecanemab-irmb), a newly FDA-approved treatment for early and mild stages of Alzheimer’s Disease.
Soleo Health CEO Drew Walk says the partnership "will afford the Alzheimer’s community continued hope while we assist patients and their caregivers as they navigate their healthcare journey."
MORE►
[Photo: Amornrat Phuchom/iStock]
Frisco’s Soleo Health Is Now the Exclusive Provider of In-Home COVID-19 Treatment for Houston Methodist
by Alex Edwards | Sep 22, 2021
Soleo Health will provide monoclonal antibody therapy, which can slow symptoms if administered within the first 10 days of COVID signs, to patients in the greater Houston area. The in-home treatment is going to be focused in communities where access to care is limited.
MORE►
by Lance Murray |
Oct 16, 2018
Also, in this roundup of people news in North Texas, you’ll find leadership appointments and changes at Texas Women's University, Soleo Health, and the Dallas Housing Authority.
MORE►
